Clinical Trial Update: GB001 in Adult Participants With Chronic Rhinosinusitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for GB001 in adults with chronic rhinosinusitis, including CRSsNP and CRSwNP; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis Without Nasal Polyps
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• GB001

Snippet

Sponsor: GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc. | Conditions: Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP), Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | Phase 2 | Status: COMPLETED | Results posted: 2021-07-30